Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials - Hanania, N A; Korenblat, P; Chapman, K R (Lancet Respir Med, 2016)
, et al.